Risk factor
Good trading liquidity
Profitability factor
Very poor margins and returns
About
Chengdu Huasun Technology Group Inc., Ltd., established in 1998, is a diversified enterprise operating from Chengdu, China. The company's core activities span both the pharmaceutical sector and the steel structure industry. In its pharmaceutical division, the company specializes in the manufacturing and distribution of various medicines, including modern and traditional Chinese remedies, as well as chemical pharmaceuticals. Additionally, it dedicates resources to the research, development, production, and marketing of biological products and advanced biotechnology drugs, particularly those targeting cardiovascular and cerebrovascular conditions. Beyond healthcare, Chengdu Huasun is also a prominent provider of comprehensive services for steel structure buildings. This includes the design, fabrication, installation, and maintenance of such constructions. The company's name was officially changed in April 2020, transitioning from its previous identity as Chengdu Taihe Health Technology Group Inc., Ltd.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers.